Health

SOURCES AND REFERENCE MATERIALS

Main Source – Cannabis Policy Impacts Public Health and Health Equity

Community Toolkit Sources

Cannabis and Pregnancy

• Early Maternal Prenatal Cannabis Use and Child Developmental Delays (JAMA)
• Associations Between Prenatal Cannabis Use and Maternal Health Outcomes (JAMA) 
• Prenatal Cannabis Use and Maternal Pregnancy Outcomes (JAMA) (ORIGINAL STUDY)
• Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function (JAMA)
• Prenatal cannabis exposure, the brain, and psychopathology during early adolescence (NMH) 
• Cannabis and Pregnancy – CDC
• Cannabis and Pregnancy – American College of Obstetricians and Gynecologists
• HEALthy Brain and Child Development (HBCD) Study (NIH)

Risks vs. Benefits

• Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies (BMJ)
• Cannabis Frequently Asked Questions (CDC) – (Cannabis Use Disorder + Risks/Benefits)
• Brain Function Outcomes of Recent and Lifetime Cannabis Use (JAMA)

Clarification of Insufficient Evidence

• The medicinal benefits of cannabis are mostly unknown (NASEM)
• The relationship between cannabis use and schizophrenia is complex (NASEM)

Vulnerable Populations

• Adolescents

• Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence (NIH)
• Cannabis Use During Adolescence and Young Adulthood and Academic Achievement: A Systematic Review and Meta-Analysis (JAMA)
• The Developmental Trajectory to Cannabis Use Disorder (American Journal of Psychiatry)
• A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses (Psychiatry Research – Volume 331)
• Cannabis and anxiety and depression in young adults: a large prospective study (NIH)

• Pre-Existing Mental Health Conditions

• Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study (Oxford Academic)
• Age-dependent association of cannabis use with risk of psychotic disorder
• What to know about cannabis and bipolar disorder (Medical News Today)
• Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research
• Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership